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Abstract
Background: Antibiotic consumption is a major driver of bacterial resistance. To address the increasing burden of
multi-drug resistant bacterial infections, antibiotic stewardship programmes are promoted worldwide to rationalize
antibiotic prescribing and conserve remaining antibiotics. Few studies have been reported from developing countries
and none from Africa that report on an intervention based approach with outcomes that include morbidity and
mortality.
Methods: An antibiotic prescription chart and weekly antibiotic stewardship ward round was introduced into two
medical wards of an academic teaching hospital in South Africa between January-December 2012. Electronic
pharmacy records were used to collect the volume and cost of antibiotics used, the patient database was analysed to
determine inpatient mortality and 30-day re-admission rates, and laboratory records to determine use of infection-
related tests. Outcomes were compared to a control period, January-December 2011.
Results: During the intervention period, 475.8 defined daily doses were prescribed per 1000 inpatient days
compared to 592.0 defined daily doses/1000 inpatient days during the control period. This represents a 19.6%
decrease in volume with a cost reduction of 35% of the pharmacy’s antibiotic budget. There was a concomitant
increase in laboratory tests driven by requests for procalcitonin. There was no difference in inpatient mortality or 30-
day readmission rate during the control and intervention periods.
Conclusions: Introduction of antibiotic stewardship ward rounds and a dedicated prescription chart in a developing
country setting can achieve reduction in antibiotic consumption without harm to patients. Increased laboratory costs
should be anticipated when introducing an antibiotic stewardship program.
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Introduction
Global concern exists that we are now facing a post-
antibiotic era [1], caused by decades of injudicious antibiotic
use driving the emergence of multi-drug resistant (MDR) Gram-
negative bacterial infections [2]. The incidence of resistant
Gram-positive bacterial infections such as methicillin-resistant
Staphylococcus aureus (MRSA) and vancomycin-resistant
enterococci (VRE) is also rising internationally and in South
Africa [3,4]. Whilst the development of novel antibiotics for
Gram-positive infections has kept pace with emergence of
resistant bacteria, the antibiotic pipeline for new drugs active
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against Gram-negative bacteria has dried up, with none
expected on the market for the next 10-15 years. The alarming
increase in rates of extended-spectrum beta-lactamase
(ESBL)-producing Gram-negative bacteria being reported from
South African hospitals [4] and countrywide outbreaks of
Carbapenem-Resistant Enterobacteriaceae (CRE) [5,6] are a
cause for grave concern. Compounding the problem is the lack
of infection prevention control capacity in South Africa [7],
which is unable to contain the spread of resistant bacterial
infections. The current situation is a direct threat to patient
safety.
Acquisition of drug-resistant hospital-acquired infection (HAI)
increases morbidity, length of hospital stay and mortality [8].
Antibiotic use drives resistance [9,10] and therefore any
unnecessary antibiotic use, irrespective of class adds to
selection pressure for resistant bacteria. A point prevalence
study of antibiotic prescriptions in Intensive Care Units across
South Africa documented patients receiving up to 10
antimicrobials simultaneously [11]. Moreover, for public and
private intensive care unit patients, inappropriate antibiotics
were prescribed in 43.5% and 73% respectively, and for an
inappropriate duration in 53.2% and 81.7% respectively.
Widespread abuse of antibiotic prescribing is also occurring in
primary care, often fuelled by patient expectations and poor
education surrounding the potential harm of antibiotics [12].
Antibiotic stewardship programmes (ASP) aim to combat
antibiotic misuse. Antibiotic stewardship is a multifaceted,
multidisciplinary team approach to optimise antibiotic
prescribing. The approach includes the formulation of policies,
use of treatment guidelines, surveillance data, education
resources, targeted interventions and audit. Interventions to
reduce excessive inpatient antibiotic prescribing reduce
resistance, HAI, and improve clinical outcome [13]. We
introduced a 2-component intervention aimed at reducing
overall antibiotic consumption without increasing morbidity and
mortality at a busy South African academic teaching hospital in
Cape Town, South Africa.
Methods
Ethics Statement
The University of Cape Town Faculty of Health Sciences
Human Research Ethics Committee (HREC) approved the
study. Approval was given for the use of oral informed consent,
as registries and databases where anonymized standard of
care data is captured do not require informed consent by the
HREC. However for this clinical audit, oral consent for the use
of anonymized routine data from drug charts and laboratory
records was requested from each patient, but was not
documented in the patient’s file.
Groote Schuur Hospital (GSH), the 945-bedded tertiary
academic teaching hospital of the University of Cape Town,
offers medical, surgical, obstetric, psychiatric and emergency
care to Cape Town’s metro west population. Consultant-led
antibiotic prescribing is the norm, with restriction of certain
antibiotics such as carbapenems, colistin, tigecycline and
vancomycin, which require release by a microbiologist or
infectious diseases physician. Web-based educational material
regarding spectra of antibiotic coverage and an interactive
case-based antibiotic tutorial are freely available on the
University’s intranet. All doctors at GSH have access to the
Western Cape Academic Hospitals Antibiotic
Recommendations [14], which are updated annually.
Beginning on 22nd November 2011, we piloted the
introduction of a dedicated antibiotic prescription chart and a
weekly antibiotic stewardship ward round in 2 general medical
wards comprising 32 beds each. These wards admit general
medical patients via the emergency unit, with patients
managed by 5 consultant-led teams who admit patients over a
24-hour period. Each ward has 4 single rooms for isolation of
patients requiring airborne or contact precautions.
Antibiotic Prescription Chart
An antibiotic prescription chart (Figure 1) was designed to
focus antibiotic prescribing on distinct infection episodes. A
patient admitted with an infection requiring antibiotics or an
inpatient admitted with a non-infectious condition who
subsequently developed a HAI was prescribed antibiotics for
‘Infection episode 1’. Any subsequent, distinct infection would
be prescribed antibiotics under ‘Infection episode 2’. The
categorization necessitated the prescribing doctor to define the
following parameters for each infection episode; the indication
for antibiotics, whether antibiotics were being prescribed on
prophylactic (P), empiric (E) or definitive (D; antibiotic
prescription based on microbiological culture and sensitivity)
grounds, whether the infection was community-acquired
(symptoms starting in the community or within 48 hours of
admission) or hospital-acquired (symptoms starting >48 hours
after hospital admission), and whether appropriate specimens
had been sent for laboratory culture before or after antibiotics
had started. Each chart permitted 3 separate infection episodes
to be documented as well as single dose prescribing. The last
page of the chart contained information for prescribers detailing
types of laboratory specimens to send, pharmacological
information on drug interactions, antibacterial spectrum and
therapeutic monitoring as well as guidance on duration of
therapy, based on the Western Cape Academic Hospitals
Antibiotic Recommendations 2012. The prescription chart was
used solely for antibiotics. Antifungals and antiviral drugs were
prescribed on the normal hospital drug chart, as were long-
term prophylactic antibiotics such as cotrimoxazole in HIV-
infected patients. Prophylactic antibiotics that were prescribed
on the antibiotic prescription chart related to surgical
prophylaxis. Antibiotic prescription charts were placed in the
emergency unit (EU) and on both medical wards. Medical
teams were instructed accordingly.
Antibiotic Stewardship Ward Rounds
Antibiotic stewardship (AS) ward rounds were conducted on
a weekly basis alternating between the 2 medical wards. An
infectious diseases specialist, consultant microbiologist,
infection prevention control nurse, and ward pharmacist
comprised the core AS team. A ward nurse and medical
registrars supervising patient care joined each round. Every
patient on the ward was reviewed, a pertinent history given and
antibiotic prescribing reviewed. Each case was then discussed,
Antibiotic Rounds Limit Antibiotic Use
PLOS ONE | www.plosone.org 2 December 2013 | Volume 8 | Issue 12 | e79747
an action plan agreed upon, and education around AS
imparted. The types of intervention recommended by the AS
team are shown in Table 1. In addition, the necessity for
indwelling urinary catheters and intravenous cannulae was
reviewed and removal undertaken whenever possible. We also
ensured that the correct infection prevention control signage
was employed. Data on antibiotic use was collected during the
AS ward rounds.
Audit of antibiotic prescription chart use
To determine compliance with chart use, point prevalence
audits of all patients on both wards were conducted once
weekly for four weeks during August / September 2012. These
were separate from the AS ward rounds. The use of a chart
when prescribing antibiotics was recorded; in addition the rate
of completion of 12 separate indicators on charts was also
assessed.
Antibiotic use
Electronic pharmacy dispensing records were used to
calculate consumption of each antibiotic, with differentiation of
oral and parenteral formulations of the same antibiotic.
Antibiotic use during the intervention period (1st January - 31st
December 2012) was compared to that during the control
period (1st January 2011 - 31st December 2011). Consumption
Figure 1.  Antibiotic Prescription Chart [25].  
doi: 10.1371/journal.pone.0079747.g001
of antibiotics was converted into defined daily dosages (DDDs)
according to the World Health Organization standard [15].
During each AS ward round, a point prevalence survey was
performed to determine the number of patients currently
receiving antibiotics and the number who had received
antibiotics earlier in their admission but were not currently
receiving them.
Laboratory tests
The number and costs of blood cultures, full blood counts,
white blood cell count differential, C-reactive protein (CRP) and
procalcitonin (PCT) requests during the control and intervention
periods was calculated from the National Health Laboratory
Service database.
Patient data
Data on in-patient mortality and re-admission to Groote
Schuur Hospital within 30-days of discharge was obtained from
the hospital electronic admissions database (Clinicom). The
Chi-Square test was used to assess statistically significant
differences in in-patient mortality and re-admission rates.
Results
Antibiotic prescription chart audit
The records of 136 patients who had been prescribed
antibiotics were audited over the 4-week period and an
antibiotic prescription chart was used in 130 (96%). In total
there were 263 unfilled fields, median 2 per chart (range 0-6).
The fields most likely to be omitted from charts were weight
(45% of charts), estimated glomerular filtration rate (36%),
allergies (32%), and the ward that the patient was on (26%).
Table 1. Types of intervention recommended by the
antibiotic stewardship team.
Stop antibiotics when there was no indication for use or if multiple antibiotics with
overlapping spectrum were prescribed
Start antibiotics when indicated
Change in dose, including adjustment for renal dysfunction and weight
Change in duration
Change in frequency of administration
Change in route of administration, most commonly switching from parental to oral
or nasogastric
De-escalation of empiric broad spectrum antibiotic to narrow-spectrum antibiotic
based on the antibiogram
Escalation of empiric narrow spectrum to empiric broad spectrum antibiotic based
on clinical deterioration of the patient and laboratory indicators, when no bacteria
had been identified
Removal of indwelling urinary catheter or intravenous cannulae
Adoption of appropriate infection prevention and control practice including isolation
of the patient, use of appropriate signs and personal protective equipment for
health care workers
doi: 10.1371/journal.pone.0079747.t001
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Point prevalence surveys of antibiotic usage
During the intervention period, 43-point prevalence surveys
of antibiotic use were conducted, covering 1249 patient
episodes. The proportion of patients who had ever received
antibiotics (currently or previously on the same admission)
remained constant during the intervention period at
approximately 65%. In contrast, there was a gradual decline in
the proportion of patients who were currently receiving
antibiotics (Figure 2).
Change in antibiotic consumption and cost
Total consumption of antibiotics, expressed in DDDs/ 1000
inpatient days on the 2 medical wards was 592.0 and 475.8
during the control and intervention periods respectively,
representing a 19.6% reduction in antibiotic consumption.
Figure 3 shows the change in use of individual antibiotics. Most
notably, there was a reduction of high-volume use antibiotics
such as parenteral ceftriaxone (-38.7 DDDs/1000 patient days),
ampicillin (-19.6) and ertapenem (-15.3). There were small
increases in the use of oral co-amoxiclav, ciprofloxacin and
clarithromycin with corresponding decreases in use of the
intravenous formulations of the same drugs. The total cost of
antibiotics during the control period was R1 068 325 compared
to R694 705 during the intervention period representing a cost
saving of R373 620 (35%).
Laboratory tests
Changes in the use of laboratory tests between control and
intervention periods are summarized in Table 2. There was an
increase in the use of most tests, notably a doubling in use of
CRP and fivefold increase in the use of PCT. Total costs for the
laboratory tests were R463 580 during the control period and
R608 232 during the intervention period representing an
increase of R144 652 (31%). The total increase in cost of
laboratory tests was driven in the main by the increase in PCT
use, whose percentage of the total costs of laboratory tests of
5% in 2011, increased to 22% of the total in 2012.
Removal of urinary catheters and peripheral
intravenous cannulae
On average, 33 patients were seen on each AS ward round.
The recorded average number of urinary catheters and
peripheral intravenous cannulae removed from patients during
each ward round was 1.9 (5.7%) and 2.1 (6.3%) respectively.
Inpatient mortality and readmission rates
During the control period, 2427 patients were admitted to the
2 medical wards with a mean age of 48 years (standard
deviation [SD] 18 years), compared to 2517 patients, mean age
of 50 years (SD 18 years) during the intervention period. A total
of 311 (12.8%) inpatients died and 226 (9.3%; 95% CI
8.2-10.5) were re-admitted to the hospital within 30 days in the
control period compared to 315 (12.5%) inpatient deaths and
213 (8.5%, 95% CI 7.4-9.6%) patients re-admitted during the
intervention period.
Discussion
The key finding of this study is that the introduction of AS
ward rounds and a dedicated antibiotic chart resulted in 19.6%
reduction in the total volume of antibiotic use and a cost
reduction of 35% of the pharmacy budget in 2 general medical
wards in a developing country setting. Importantly, the
intervention was not associated with ‘collateral damage’ i.e.
unpredicted adverse effects, in terms of inpatient mortality or
30-day readmission rate to the hospital. However, a
Figure 2.  Results of 43-point prevalence surveys undertaken during the intervention period (January–December 2012),
showing proportion of patients during their current admission who ever received antibiotics (diamonds) and the
proportion currently receiving antibiotics (crosses).  
doi: 10.1371/journal.pone.0079747.g002
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concomitant increase in laboratory costs was incurred, mainly
due to an increase in the use of procalcitonin tests.
This study adds to the pertinent body of knowledge by
demonstrating the utility of an AS intervention in a developing
country such as South Africa. In the latest Cochrane
Systematic Review of interventions to improve antibiotic
prescribing practices for hospital inpatients, none of the 89
studies included in the review were from Africa and only 5 were
from developing countries i.e. Brazil, Colombia and Thailand
[13].
The effect of the AS programme on the profile of Gram-
negative bacterial antibiotic resistance in our hospital is being
studied longitudinally. However, in the face of increasing
countrywide antibiotic resistance and transfer of patients into
our hospital already colonized or infected with MDR infections,
demonstrating a reduction due to the intervention will be
challenging.
We witnessed a steady decline in the number of patients still
on antibiotics when seen on the weekly ward rounds due to
early discontinuation of the antibiotics initially started in the EU
or ward. The commonest reasons for this were inadequate
indication for antibiotics or an inappropriate duration of
antibiotics charted by the admitting physician. For example,
prior to the intervention, it was commonplace for ceftriaxone to
be prescribed for 2 weeks for all patients admitted with
Figure 3.  Change in Defined Daily Doses of antibiotics
per 1000 inpatient days, between control period (January–
December 2011) and intervention period (January–
December 2012) on 2 general medicine wards.  
doi: 10.1371/journal.pone.0079747.g003
Table 2. Number of laboratory tests performed during the
control and intervention phase.
 Control (2011) Intervention (2012) Percentage Change
Full blood count 5 645 5 853 3.7
White blood count 364 446 22.5
C-Reactive Protein 310 619 100
Procalcitonin 61 367 502
Blood Culture 1 924 1 896 -1.5
doi: 10.1371/journal.pone.0079747.t002
community-acquired pneumonia or sepsis of unknown cause.
Following the introduction of AS ward rounds, this duration
decreased to a standard of 5 days, except for infections such
as meningitis and others requiring prolonged duration of
antibiotics. We also demonstrated an increase in initial use of
oral over parenteral antibiotics, and an increase in earlier
parenteral to oral switch. This was particularly evident for
ciprofloxacin, clarithromycin and co-amoxiclav.
Ideally, one would use a stepwise introduction of a single
intervention to judge benefit. On this occasion, we opted for a
dual intervention strategy as the antibiotic prescription chart
also acted as an audit tool. Although we cannot disregard the
possibility that the chart itself may have contributed to the
reduced antibiotic use, we hypothesize that the major factor
effecting change was the AS ward round. Ward rounds were
held once weekly, yet the early stopping of antibiotics
commonly occurred prior to the weekly ward round, indicating
change in prescribing practice. Furthermore, the AS ward
round was used to train and transfer skills, particularly in
complex cases where there is often a question of equipoise. A
number of studies from different healthcare settings in the
United States support our hypothesis, having shown reduction
in antibiotic prescribing and cost following input by trained
specialists in the decision making process [16-19].
Antibiotic restriction reduces antibiotic use and cost [20].
However, limiting one antibiotic or antibiotic class commonly
leads to increased prescribing of other antibiotics that are not
restricted. This ‘squeezed balloon effect’ ensures that total
volume of antibiotic use may not change. Furthermore there is
no evidence that antibiotic restriction leads to long-term
reduction in resistance. In our own setting, an antibiotic
restriction programme has been in place for many years at
Groote Schuur Hospital, whereas at the neighbouring
Tygerberg Hospital, a tertiary academic teaching hospital of
University of Stellenbosch, a very similar antibiotic resistance
profile is present despite the hospital having abandoned
antibiotic restriction 7 years ago.
A number of studies have documented benefit from
introduction of dedicated antibiotic prescription charts. Closest
to our own chart design, Durbin et al reported reduction in
inappropriate prophylactic antibiotic use and mean duration of
prophylactic antibiotics, as well as an increase in appropriate
antibiotic prescribing in urology patients from 38% to 89%,
following an introduction of a new chart [21]. Similarly, a study
that introduced a dedicated prescription chart in an 800-bedded
hospital requiring an indication and defined duration to be
charted, reduced overall antibiotic use by 30% and the overall
hospital pharmacy budget by 2% over 25 months [22].
Laboratory costs associated with the introduction of the AS
programme at GSH increased. A gatekeeping strategy was in
place to limit the use of CRP. However, no such strategy was
in place for PCT at the start of our intervention. The majority of
the excess costs were attributed to inappropriate PCT use,
often with repeated or serial measurements. Although serial
measurement of PCT has been shown to be of benefit in
guiding when to stop antibiotics, particularly in the intensive
care unit setting [23,24], in a resource-poor setting such as the
South African public health system, this is not a strategy that
Antibiotic Rounds Limit Antibiotic Use
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has been adopted as part of hospital practice. Furthermore, >2
PCT estimations were occasionally requested by doctors in an
attempt to define whether to start antibiotics. This was also
deemed inappropriate practice. Guidelines for the use of PCT
were introduced resulting in a reduction of tests performed in
the last quarter of the intervention period. This illustrates the
importance of taking into account how an AS programme can
impact on hospital finances over and above just the antibiotic
costs. Although savings in antibiotic costs were diminished by
the increase in laboratory costs, we did not factor in savings
from reduced use of equipment to deliver intravenous
antibiotics, reduction in length of stay of patients having
switched earlier from intravenous to oral antibiotics and other
cost savings. Therefore, the overall reduction in cost of R228,
968 represents an underestimate.
There are several limitations to our study. As highlighted, the
use of a 2-part intervention makes it difficult to dissect out the
contribution made by the chart or the ward rounds. Secondly,
the AS team described in this intervention is not reproducible
outside of a tertiary, or rarely a secondary level hospital in
South Africa or many developing countries. Infectious diseases
specialists and microbiologists are usually domiciled at tertiary
centres, and although they perform outreach and support to
primary level facilities, the same composition of AS team is
unlikely to be replicated. However, the principle of stewardship
and a team constructed around key role players such as
pharmacists and physicians with appropriate training could be
introduced at any health care facility. One of the objectives of
the South African Antibiotic Stewardship Programme [25] is to
develop training programmes for pharmacists and non-
specialist physicians to enable AS in all healthcare facilities.
We did not record baseline demographic patient information
or severity of illness indicators, which leaves us unable to
accurately assess differences in the inpatient populations
during the control and intervention years. However, we did not
witness any gross differences in patient profile during the 2
years, both of which had mild influenza seasons. Our results to
date do not allow us to determine what effect the intervention
has had on antibiotic resistance rates in our hospital. Although
antibiotic consumption is a major driver of resistance,
introduction of resistant organisms from other hospitals will
confound the issue. Our intervention on 2 medical wards, does
not allow us to generalize in terms of its applicability in different
clinical settings. However, preliminary results from a similar
ongoing intervention in the general surgical wards at our
hospital, is also showing a reduction in total volume of antibiotic
use and pharmacy cost (data not shown).
Future research questions will be aimed at addressing the
issues of reproducibility of the intervention in different
healthcare settings, change in resistance patterns, and
optimizing individual patient outcomes through AS. Reducing
hang time (the time from writing up the prescription to entry of
antibiotic into the patient), optimizing antibiotic dose and
rational therapeutic drug monitoring are important research
questions to address.
We face an uncertain future of MDR Gram-negative bacterial
infections. The rise in CRE and its characterization has
highlighted the broad resistance genes these bacteria carry
and the ability of most antibiotics to select out these resistant
organisms. Hence, interventions to reduce antibiotic
consumption are urgently needed to limit the emergence of
resistant organisms and must be introduced alongside
strengthening of basic infection control practices, such as hand
washing. Antibiotic prescription charts and more importantly the
rollout of AS ward round activity by AS teams in every
healthcare institution will be critical in reducing the volume of
antibiotic use and slowing the march towards a post-antibiotic
era.
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